摘要 |
Disclosed are various controlled release pharmaceutical compositions that include an agent that enhances or modulates the endogenous production of nitric oxide in a mammal. Controlled release pharmaceutical compositions of L-arginine, its salts, peptides, and biological equivalents, together with methods of using the compositions are included. Also included are controlled release pharmaceutical compositions of botanical extracts that modulate or enhance the production of nitric oxide, either alone or in combination with L-arginine or its biological equivalent.
|